RIDDLE&CODE-GMBH
Riddle&Code GmbH is pleased to announce John Calian as the new CEO of the company.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220823005122/en/
"I am grateful to have been selected as Riddle&Code's next CEO. We are an organisation led by a purpose – to onboard industrial machines to Web3. It is a privilege to lead a team dedicated to machine-driven token economies, enabling sustainable, green, resilient energy systems," said Calian. "That is the mission of our company. I will do my best to serve the team and our customers by enabling our leaders and people to do their best work."
This decision comes at a momentous time, as Riddle&Code evolves into a product-led service company specialising in Web3 infrastructure and establishing the unique RDDL Network blockchain, which provides the cornerstones for decentralised, secure, and trusted machine economies. Riddle&Code is preparing to be a key contributor to this network and aims to provide the best products, services, and solutions to make this vision flourish.
Working with enterprise partners such as Wien Energie, Daimler Mobility, Evonik, Litebit, and Telekom Innovation Laboratories (T-Labs), Riddle&Code has built an extensive portfolio of blockchain-powered software and hardware products across key industry segments, highlighted by renewable energy producers, electric vehicle manufacturers and large scale energy storage systems providers.
"We are at a natural turning point for the company, and John brings the leadership and expertise needed for Riddle&Code to enter this next phase. Our new purpose is to share our established knowledge and onboard as many industries as possible to Web3 to shape the future of interconnecting token economies with the RDDL Network. This goes way beyond the wildest ambitions of current token projects and energy tech companies." ~ Tom Fürstner, Founder and CTO of Riddle&Code.
The landscape for decentralised infrastructure is rapidly changing, and there has been an increase in demand for blockchain-based software systems due to the ongoing shift towards Web3. This new era requires industries to set up new operating and business models, combining old strengths with a new way of thinking.
Riddle&Code is now focused on being a key player in onboarding industries to Web3 and will provide specific products and services. Co-Founder and outgoing CEO Alexander Koppel will continue as Advisor to the CEO in the future and further support the company's mission. This announcement is the logical next step in the further evolution and continued progress of Riddle&Code and its subsidiary companies.
About Riddle&Code
Riddle&Code is a product-led services company specialising in onboarding industries to Web3. The company is the main driver for a world of interconnected token economies by enabling sustainable, green, and resilient machine industries. Riddle&Code offers various solutions to tailor industry-specific hardware wallets and an application suite to build on decentralised blockchains, mainly contributing to the RDDL Network blockchain protocol.
More information: www.riddleandcode.com
About the RDDL Network
The RDDL Network is a decentralised, industrial machine-powered blockchain protocol that uses a unique Proof-of Productivity (PoP) consensus mechanism that proves identity, data accuracy, and usage for all types of machines. It addresses infrastructure and standards as a whole and is designed to shape the future of interconnected token economies for the fourth industrial revolution.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220823005122/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Coulson Aviation Announces Launch of Boeing 767 VLAT Program22.12.2025 14:03:00 CET | Press release
Advancing the Next Generation of High-Capacity Aerial Firefighting Coulson Aviation USA has announced the launch of its Boeing 767 Very Large Airtanker (VLAT) program, marking a significant advancement in the evolution of aerial firefighting capability. The program is intended to provide a sustainable replacement for legacy VLAT platforms nearing the end of their operational service life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251222917730/en/ A cross-sectional view of Coulson Aviation’s Boeing 767 Very Large Airtanker (VLAT) illustrates the integration of the RADS retardant delivery system and the next generation of high-capacity, sustainable aerial firefighting design. The recent grounding of the MD11 and DC10 fleets has highlighted a structural challenge for firefighting agencies worldwide. As older widebody aircraft are retired, the industry faces a significant reduction in high-capacity, large-scale retardant de
Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 10:00:00 CET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in
Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 10:00:00 CET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration
Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 10:00:00 CET | Press release
Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press release
First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER studyIn MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% vs. 3.2% for placebo), while providing clinically meaningful and statistically significant improvements across all patient-reported outcomesWith longer-term follow-up, 3 out of 4 patients treated with pimicotinib achieved response per RECIST v1.1, and treatment continued to be well-toleratedApproval strengthens Merck’s leadership in rare tumors, with additional ongoing regulatory filings for pimicotinib underway globally Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom